A proven roadmap for innovation and commercialization
We empower inventors — paving pathways, clearing obstacles and dedicating significant resources to technology transfer.
Impact Dashboard
This is WashU Innovation
The Office of Technology Management assists WashU faculty in the transfer of technology from the lab to the global marketplace.
Explore our innovation community
Upcoming Events
NEURO360
Introducing NEURO360 – Advancing Neuroscience Technologies to improve cognitive wellness
Needlemans commit $15 million to boost drug discovery
A generous gift from longtime benefactors of Washington University School of Medicine in St. Louis establishes the Needleman Program for Innovation and Commercialization. For a select number of projects, the new program will provide funding to help move promising therapeutics towards the stage where the Food and Drug Administration grants investigational new drug (IND) status.
In the news
Wearable, light-based brain-imaging tech to be commercialized with aid of NIH grant
Wearable brain-imaging tech aims to reveal how the brain works in natural, realistic situations. Washington University faculty members Joseph P. Culver, Jason Trobaugh and Ed Richter, along with Adam Eggebrecht, have received a grant from the NIH to develop and commercialize a brain-imaging cap that uses LED light to gauge brain activity.
Washington University receives NSF Engines Development Award
A team led by Washington University in St. Louis has been awarded $1 million over two years from the U.S. National Science Foundation’s Regional Innovation Engines, or NSF Engines, program. The team, called NEURO360, is among some 40 teams nationwide to receive NSF Engines Development Awards, which aim to spur collaborations to create economic, societal and technological opportunities for their respective regions.
Needleman innovation program seeks proposals for therapeutic development
The newly established Needleman Program for Innovation and Commercialization at Washington University School of Medicine in St. Louis is seeking proposals to fund promising new therapeutic candidates with the goal of achieving designation as investigational new drugs by the Food and Drug Administration (FDA).
#WashUInnovators
A blood test developed at #WashUMed has proven highly accurate in detecting early signs of Alzheimer’s, even among patients not yet experiencing cognitive declines.
Announcements
Yang elected senior member of National Academy of Inventors
Genin, Guilak named to National Academy of Inventors
University again named to top 100 patent list
Resources for Students & Alumni
The Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship serves as the primary resource for students and alumni.